Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
13626
PUT
Eton Pharmaceutcials
ETON
$1.59B
| $3K | ﹤0.01% |
500
-500
| -50% | -$2.11K |
2024 Q2
1 quarter
|
|
|
CLLS
13627
PUT
Cellectis
CLLS
$142M
| $3K | ﹤0.01% |
1,400
+300
| +27% | +$652 |
2024 Q2
1 quarter
|
|
|
PARAW
13628
Banzai International Warrant
PARAW
$112K
| $2.97K | ﹤0.01% |
367,121
+333,003
| +976% | +$3.36K |
2023 Q3
4 quarters
|
|
|
BLEUR
13629
DELISTED
bleuacacia ltd Rights
BLEUR
| $2.97K | ﹤0.01% |
+95,175
| New | +$3.48K |
2024 Q3
0 quarters
|
|
|
HTBK
13630
CALL
DELISTED
Heritage Commerce
HTBK
| $2.96K | ﹤0.01% |
300
-500
| -63% | -$4.88K |
2022 Q4
7 quarters
|
|
|
TMTCR
13631
DELISTED
TMT Acquisition Corp Rights
TMTCR
| $2.96K | ﹤0.01% |
10,844
-100
| -0.9% | -$32 |
2023 Q3
4 quarters
|
|
|
THTX
13632
CALL
DELISTED
Theratechnologies
THTX
| $2.95K | ﹤0.01% |
+2,400
| New | +$3.25K |
2024 Q3
0 quarters
|
|
13633
CALL
Ocean Power Technologies
OPTT
$8.64M
| $2.94K | ﹤0.01% |
+630
| New | +$4.67K |
2024 Q3
0 quarters
|
|
13634
CALL
AudioCodes
AUDC
$261M
| $2.92K | ﹤0.01% |
300
-5,200
| -95% | -$54.1K |
2022 Q3
8 quarters
|
|
|
ARBK
13635
PUT
Argo Blockchain
ARBK
$33.5M
| $2.9K | ﹤0.01% |
11
-36
| -77% | -$9.9K |
2023 Q3
4 quarters
|
|
|
AUTL
13636
PUT
Autolus Therapeutics
AUTL
$487M
| $2.9K | ﹤0.01% |
800
-2,100
| -72% | -$8.38K |
2023 Q4
3 quarters
|
|
|
GLLIW
13637
DELISTED
Globalink Investment Inc. Warrants
GLLIW
| $2.88K | ﹤0.01% |
113,755
+13,167
| +13% | +$431 |
2024 Q2
1 quarter
|
|
|
RNLX
13638
CALL
DELISTED
Renalytix plc American Depositary Shares
RNLX
| $2.88K | ﹤0.01% |
+13,700
| New | +$4.38K |
2024 Q3
0 quarters
|
|
13639
PUT
HF Foods Group
HFFG
$89M
| $2.86K | ﹤0.01% |
800
-6,800
| -89% | -$22.1K |
2024 Q1
2 quarters
|
|
13640
CALL
Grove Collaborative
GROV
$44.4M
| $2.83K | ﹤0.01% |
2,100
+1,800
| +600% | +$2.57K |
2024 Q1
2 quarters
|
|
13641
PUT
National CineMedia
NCMI
$201M
| $2.82K | ﹤0.01% |
400
+200
| +100% | +$1.22K |
2024 Q1
2 quarters
|
|
13642
CALL
Focus Universal
FCUV
$3.04M
| $2.8K | ﹤0.01% |
+27
| New | +$2.88K |
2024 Q3
0 quarters
|
|
13643
CALL
Shore Bancshares
SHBI
$762M
| $2.8K | ﹤0.01% |
+200
| New | +$2.68K |
2024 Q3
0 quarters
|
|
13644
60 Degrees Pharmaceuticals Warrant
SXTPW
$40.7K
| $2.79K | ﹤0.01% |
46,273
+7,231
| +19% | +$417 |
2024 Q1
2 quarters
|
|
|
FM
13645
PUT
DELISTED
iShares Frontier and Select EM ETF
FM
| $2.75K | ﹤0.01% |
+100
| New | +$2.76K |
2024 Q3
0 quarters
|
|
13646
PUT
Ecovyst
ECVT
$1.14B
| $2.74K | ﹤0.01% |
+400
| New | +$3.05K |
2024 Q3
0 quarters
|
|
13647
Tenon Medical Inc Warrant
TNONW
$1.35K
| $2.74K | ﹤0.01% |
89,766
+23,748
| +36% | +$1.09K |
2023 Q3
4 quarters
|
|
13648
PUT
Flux Power
FLUX
$11.1M
| $2.74K | ﹤0.01% |
900
-15,800
| -95% | -$53.2K |
2024 Q1
2 quarters
|
|
13649
CALL
Nature's Sunshine
NATR
$218M
| $2.72K | ﹤0.01% |
200
-1,000
| -83% | -$14.3K |
2024 Q2
1 quarter
|
|
|
BTLN
13650
PUT
Brightline Interactive
BTLN
$14.3M
| $2.72K | ﹤0.01% |
+450
| New | +$3.21K |
2024 Q3
0 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.